David Bernstein, M.D.

David Bernstein, MD, is Professor Emeritus of Medicine in the Division of Immunology and Allergy at the University of Cincinnati College of Medicine where he is co-director of the Allergy Fellowship training program. He is former Principal Investigator of a training grant for 3 funding cycles through the National Institute of Allergy and Infectious Diseases (NIAID), the aim of which was to provide research training and career development for Allergy fellows pursuing academic research careers.

Dr. Bernstein has authored or co-authored over 270 original publications. He has been engaged in the practice of Allergy and Clinical Immunology for the past 40 years. Major research interests include new therapies for asthma and allergic disorders, environmental causes of asthma, allergen immunotherapy and occupational asthma. Through much of his career, he had procured extramural funding awards (including R01s) through NIOSH/CDC and NIEHS. He served on the College Board of Regents and is former Chair of the American Board of Allergy and Immunology.

Dr. Bernstein has directed the North American Immunotherapy Safety Surveillance Study since 2008. He has received the Distinguished Clinician Award from the American Academy of Allergy Asthma and Immunology and this year received the Distinguished Alumni Award from the University of Cincinnati College of Medicine.

Please complete this form:

  • To subscribe to receive information updates about products and services from Aquestive Therapeutics, or to receive information about Aquestive-sponsored clinical trials, please check the box below. Please also review our privacy policy, which describes how we use and process your data. You may also contact us at any time by emailing info@aquestive.com or by calling 1-908-941-1900.

Please complete the form below and click SEND to receive a copy of “Overcoming Solubility and Permeability Challenges,” a case study detailing the achievements made by Aquestive’s formulation team to create the diazepam buccal film.

  • To subscribe to receive marketing updates about diazepam buccal film and other products and services from Aquestive, please complete the form below. Please also review our privacy policy, which describes how we use and process your data. You may also contact us at any time by emailing busdev@aquestive.com.

Please complete the form to receive a demonstration kit for our PharmFilm® technology.

  • To subscribe to receive marketing updates about our PharmFilm® technology and other products and services from Aquestive, please complete the form below. Please also review our privacy policy, which describes how we use and process your data. You may also contact us at any time by emailing busdev@aquestive.com.

Please complete this form:

  • To subscribe to receive marketing updates about products and services from Aquestive Therapeutics, or to receive information about Aquestive-sponsored clinical trials, please check the box below. Please also review our privacy policy, which describes how we use and process your data. If for any reason you no longer wish to receive information on Aquestive-sponsored clinical trials, you can contact us at any time by emailing clinicaltrials@aquestive.com.

Whether we are partnering to out license our PharmFilm® technology or in-licensing adjacent assets, Aquestive works hand-in-hand with our partners to address their toughest clinical and business challenges. To learn more, please complete the following form:

  • To subscribe to receive information updates about products and services from Aquestive Therapeutics, or to receive information about Aquestive-sponsored clinical trials, please check the box below. Please also review our privacy policy, which describes how we use and process your data. You may also contact us at any time by emailing busdev@aquestive.com.

Please complete the form below and click submit to receive a copy of “The Art of LGS Book.”